Tuesday, September 29, 2020, 9:00 am to 3:45 pm
The NIH's National Institute of Nursing Research (NINR) will hold a virtual workshop on innovative models of care for reducing inequities in maternal health. The workshop will explore how nurses, midwives, and birth companions can improve maternal and infant health, specifically for women in U.S. communities affected by structural and health inequalities. This event will be available to join via VideoCast.
Wednesday, September 30, 2020 to Thursday, October 1, 2020 (register by September 28)
With improved rates of survival in childhood illnesses in the United States and globally, individuals are living longer with one or more chronic conditions. To meet the needs of diverse populations with chronic physical/medical conditions or intellectual/developmental disabilities as they transition from pediatric- to adult-centric services, barriers to successful health care transition (HCT), methods and measures for defining HCT, and the identification of promising practices must be better understood.
The purpose of this virtual workshop is to bring together experts from various backgrounds and disciplines to explore research areas of high priority for youth regarding needed transition services/support as part of routine care. Given increasing coordination efforts on the topic of health care transition across the United States Department of Health and Human Services (HHS), the National Institutes of Health (NIH) is uniquely poised to coordinate health care transition research efforts as they relate to each Institute’s, Center’s, and Office’s (ICO) mission and vision.
The deadline to register for this workshop is Monday, September 28. The workshop will be broadcast through the NIH Videocast website. The videocast link will be emailed to workshop registrants closer to the meeting date.
Monday, October 26, 2020, 10:00 am to Tuesday, October 27, 2020, 2:30 pm (register by October 22)
The purpose of this virtual conference, organized by the NIH's Cancer and Aging Interest Group in collaboration with the National Cancer Institute (NCI), National Institute on Aging (NIA), and National Institute of Environmental Health Sciences (NIEHS), is to increase awareness of the impact of aging in cancer risk, with special consideration of cancer in the elderly. The invited experts will discuss the overlap and divergent paths of cancer and aging biology, provide input regarding existing gaps in knowledge, and facilitate the prioritization of the scientific areas for further research efforts.
Registration for this event closes Thursday, October 22.
Thursday, October 29, 2020, 11:00 am to Friday, October 30, 2020, 5:00 pm (registration required)
The past year has brought unprecedented changes to the world with the COVID-19 pandemic. In response to this challenge, the scientific community has mobilized on many fronts with advances in vaccines, diagnostics, treatments, pathology, immunology, virology, structural biology, cell biology, and many other areas. To help facilitate interactions and highlight the work of investigators from the NIH and the Food and Drug Administration (FDA), the NIH COVID-19 scientific interest group is hosting a virtual workshop for NIH and FDA staff. We expect to have a full and exciting agenda of cutting-edge talks and poster sessions. We hope that this will be a major opportunity for researchers to share their most exciting COVID-19 research.
This virtual workshop will be limited to members of the NIH and FDA communities and registration is required. Abstract submission will close on September 21, though registration will continue after that.
Monday, November 16, 2020 to Tuesday, November 17, 2020 (registration required)
The goal of this virtual meeting is to critically address the wealth of new data generated by bulk and single-cell molecular, imaging and computational approaches that are increasingly revealing how the genome folds to faithfully accommodate gene expression programs and cell fate decisions. The goal is to advance an understanding of how transcriptional enhancers function, how to separate cause and effect, and to identify critical questions that will guide future directions.
Monday, November 30, 2020, 9:30 am to Tuesday, December 1, 2020, 4:30 pm (registration required)
This virtual workshop, co-hosted by the NIH's National Center for Advancing Translational Sciences (NCATS) and the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA), will bring together scientists, therapeutic developers, and patient representatives to focus on immunogenicity issues related to the systemic administration of AAV gene therapy products and identify solutions for those issues.
Goals for this meeting include:
- Exchange lessons learned from AAV gene therapy clinical trials to date, including clinical manifestations of immunogenicity, methods for evaluating the risk of immune responses, effective immunosuppressive protocols and other clinical topics.
- Explore emerging methods and technologies for modulating immune responses to AAV gene therapies with respect to both reducing the immunogenicity of AAV vector molecules and tolerizing strategies.
- Review basic, preclinical and clinical knowledge gaps, including the adequacy of current in-silico algorithms, preclinical models, assays and knowledge-sharing mechanisms to address those gaps.
- Identify and explore potential solutions.
The deadline for abstract submission is October 1, 2020.
Wednesday, January 27, 2021 to Thursday, January 28, 2021 (registration required)
National Cancer Institute (NCI) Shady Grove campus, 9609 Medical Center Drive, Rockville, MD 20850
The Hispanic/Latino population, one of the fastest growing minority populations in the U.S., is estimated to reach 119 million by 2060. This diverse population (by country of origin, ancestry and race) and the anticipated demographic shift (e.g., immigrant vs. U.S.-born) may represent significant implications for cancer burden in the U.S. Some Hispanic populations have higher incidence and mortality rates for cancers of the liver, stomach, cervix, and gallbladder compared to other U.S. race/ethnic groups. The higher incidence and mortality rates of these cancers parallel observations for cancer burden in several Latin American countries. We do not fully understand the etiology that contributes to these differential cancer rates.
This NCI-sponsored workshop will consider the challenges, identify opportunities, and develop ideas for increasing Hispanic representation in cancer epidemiological studies. Three overarching objectives will govern the meeting: to identify scientific gaps and opportunities for cancer epidemiologic research in Hispanic populations, to encourage the use of existing resources and identify gaps in resources to enable cancer epidemiological research in Hispanic populations, and to facilitate and coordinate cross-discipline collaboration to inform research in Hispanic populations.